Biotech News
Merus to Present at the Canaccord Genuity 45th Annual Growth Conference
ir.merus.nl2026-05-06 14:55 EST
UTRECHT, The Netherlands and CAMBRIDGE, Mass. , Aug. 06, 2025 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq: MRUS), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics ® , Triclonics ® and ADClonics ® ), today announced that Bill